17547

590006

AMRUTANJAN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

AMRUTAJAN HEALTH LTD Share Price Today

AMRUTAJAN HEALTH LTD is currently trading at ₹537.3, up by ₹1.7 from the previous close. The stock touched an intraday high of ₹544.95 and a low of ₹535.20 during the latest trading session. Over the past one year, AMRUTAJAN HEALTH LTD has delivered a loss of 26.61%, while the stock has declined 4.53% in the last one month.

AMRUTAJAN HEALTH LTD performance

Today’s low Today’s high
₹ 535.20 ₹ 544.95
₹ 537.30
52 week low 52 week high
₹ 486.00 ₹ 790.95
₹ 537.30
Open Price ₹ 541.05
Prev. Close ₹ 535.60
Volume (Shares) 21414.00
Total traded value ₹ 115.05
Upper Circuit ₹ 642.70
Lower Circuit ₹ 428.50
info

Investment Returns

Over 1 Month -4.53% Over 3 Months 3.48% Over 6 Months -21.42% Over 1 Year -26.61%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

AMRUTAJAN HEALTH LTD fundamentals


  • Market cap (Cr) 1,553.40
  • P/E Ratio (TTM) 26.86
  • Beta 0.50
  • Book Value / share 128.06
  • Return on equity 16.53%
  • EPS (TTM) 22.31
  • Dividend yield 0.91%
  • Net profit/quarter (Cr) 16.19
info icon alternate text
  • Market cap (Cr) 1,555.50
  • P/E Ratio (TTM) 26.86
  • Beta 0.38
  • Book Value / share 128.06
  • Return on equity 16.53%
  • EPS (TTM) 22.31
  • Dividend yield 0.91%
  • Net profit/quarter (Cr) 16.19
info icon alternate text

AMRUTAJAN HEALTH LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 149.77
Operating Expense 125.88
Net Profit 16.19
Net Profit Margin (%) 10.80
Earnings Per Share (EPS) 5.60
EBITDA 22.68
Effective Tax Rate (%) 22.93
Particulars DEC 2025 (Values in Cr)
Revenue 141.04
Operating Expense 117.53
Net Profit 19.45
Net Profit Margin (%) 13.79
Earnings Per Share (EPS) 6.73
EBITDA 28.03
Effective Tax Rate (%) 26.21
Particulars SEP 2025 (Values in Cr)
Revenue 117.70
Operating Expense 102.78
Net Profit 13.96
Net Profit Margin (%) 11.86
Earnings Per Share (EPS) 4.83
EBITDA 20.82
Effective Tax Rate (%) 27.32
Particulars JUN 2025 (Values in Cr)
Revenue 94.05
Operating Expense 87.17
Net Profit 8.31
Net Profit Margin (%) 8.83
Earnings Per Share (EPS) 2.87
EBITDA 12.87
Effective Tax Rate (%) 26.39
Particulars MAR 2025 (Values in Cr)
Revenue 135.41
Operating Expense 119.37
Net Profit 15.18
Net Profit Margin (%) 11.21
Earnings Per Share (EPS) 5.25
EBITDA 22.52
Effective Tax Rate (%) 27.22
Particulars MAR 2026 (Values in Cr)
Revenue 502.55
Operating Expense 433.39
Net Profit 57.92
Net Profit Margin (%) 11.52
Earnings Per Share (EPS) 20.03
EBITDA 84.41
Effective Tax Rate (%) 25.63
Particulars MAR 2025 (Values in Cr)
Revenue 451.82
Operating Expense 400.36
Net Profit 50.83
Net Profit Margin (%) 11.25
Earnings Per Share (EPS) 17.58
EBITDA 75.88
Effective Tax Rate (%) 26.47
Particulars MAR 2024 (Values in Cr)
Revenue 421.23
Operating Expense 375.64
Net Profit 44.97
Net Profit Margin (%) 10.67
Earnings Per Share (EPS) 15.50
EBITDA 68.17
Effective Tax Rate (%) 27.39
Particulars MAR 2023 (Values in Cr)
Revenue 379.64
Operating Expense 340.53
Net Profit 39.83
Net Profit Margin (%) 10.49
Earnings Per Share (EPS) 13.65
EBITDA 58.94
Effective Tax Rate (%) 25.74
Particulars MAR 2022 (Values in Cr)
Revenue 405.84
Operating Expense 330.64
Net Profit 67.19
Net Profit Margin (%) 16.55
Earnings Per Share (EPS) 23.05
EBITDA 94.86
Effective Tax Rate (%) 25.82
Particulars MAR 2016 (Values in Cr)
Book Value / Share 74.40
ROE % 20.21
ROCE % 31.43
Total Debt to Total Equity 0.02
EBITDA Margin 18.63
Particulars MAR 2015 (Values in Cr)
Book Value / Share 64.97
ROE % 16.18
ROCE % 25.28
Total Debt to Total Equity 0.06
EBITDA Margin 16.05
Particulars MAR 2014 (Values in Cr)
Book Value / Share 61.06
ROE % 14.51
ROCE % 21.52
Total Debt to Total Equity 0.13
EBITDA Margin 16.64
Particulars MAR 2013 (Values in Cr)
Book Value / Share 56.29
ROE % 12.69
ROCE % 18.14
Total Debt to Total Equity 0.23
EBITDA Margin 14.95
Particulars MAR 2012 (Values in Cr)
Book Value / Share 264.62
ROE % 10.78
ROCE % 16.36
Total Debt to Total Equity 0.29
EBITDA Margin 14.94
Particulars MAR 2025 (Values in Cr)
Book Value / Share 112.97
ROE % 16.53
ROCE % 21.89
Total Debt to Total Equity 0.01
EBITDA Margin 16.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share 99.78
ROE % 15.53
ROCE % 20.84
Total Debt to Total Equity 0.00
EBITDA Margin 16.20
Particulars MAR 2023 (Values in Cr)
Book Value / Share 99.47
ROE % 14.33
ROCE % 18.81
Total Debt to Total Equity 0.00
EBITDA Margin 15.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 90.70
ROE % 27.96
ROCE % 36.78
Total Debt to Total Equity 0.00
EBITDA Margin 23.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 73.75
ROE % 32.64
ROCE % 42.34
Total Debt to Total Equity 0.01
EBITDA Margin 25.89
Particulars MAR 2016 (Values in Cr)
Cash & Short Term Investments 48.24
Total Assets 140.43
Total Liabilities 140.43
Total Equity 108.74
Share Outstanding 1
Price to Book Ratio 5.06
Return on Assets (%) 14.65
Return on Capital (%) 18.5
Particulars MAR 2015 (Values in Cr)
Cash & Short Term Investments 37.88
Total Assets 123.90
Total Liabilities 123.90
Total Equity 94.95
Share Outstanding 1
Price to Book Ratio 6.67
Return on Assets (%) 12.02
Return on Capital (%) 15.29
Particulars MAR 2014 (Values in Cr)
Cash & Short Term Investments 35.20
Total Assets 120.26
Total Liabilities 120.26
Total Equity 89.23
Share Outstanding 1
Price to Book Ratio 1.89
Return on Assets (%) 10.34
Return on Capital (%) 12.8
Particulars MAR 2013 (Values in Cr)
Cash & Short Term Investments 14.90
Total Assets 124.15
Total Liabilities 124.15
Total Equity 82.26
Share Outstanding 1
Price to Book Ratio 1.93
Return on Assets (%) 8.14
Return on Capital (%) 10.4
Particulars MAR 2012 (Values in Cr)
Cash & Short Term Investments 15.23
Total Assets 124.20
Total Liabilities 124.20
Total Equity 77.26
Share Outstanding 0
Price to Book Ratio 2.77
Return on Assets (%) 7.75
Return on Capital (%) 9.9
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 83.15
Total Assets 421.38
Total Liabilities 421.38
Total Equity 326.61
Share Outstanding 2
Price to Book Ratio 5.71
Return on Assets (%) 12.06
Return on Capital (%) 15.56
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 26.60
Total Assets 366.87
Total Liabilities 366.87
Total Equity 288.48
Share Outstanding 2
Price to Book Ratio 6.20
Return on Assets (%) 12.25
Return on Capital (%) 15.59
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 70.31
Total Assets 362.09
Total Liabilities 362.09
Total Equity 290.77
Share Outstanding 2
Price to Book Ratio 5.78
Return on Assets (%) 11.00
Return on Capital (%) 13.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 87.75
Total Assets 349.86
Total Liabilities 349.86
Total Equity 265.12
Share Outstanding 2
Price to Book Ratio 8.75
Return on Assets (%) 19.20
Return on Capital (%) 25.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 139.31
Total Assets 274.27
Total Liabilities 274.27
Total Equity 215.56
Share Outstanding 2
Price to Book Ratio 7.71
Return on Assets (%) 22.31
Return on Capital (%) 28.39
Particulars MAR 2016 (Values in Cr)
Net Income 32.68
Cash from Operations 32.18
Cash from Investing 4.16
Cash from Financing -13.10
Net change in Cash 11.75
Free Cash Flow 34.38
Particulars MAR 2015 (Values in Cr)
Net Income 24.14
Cash from Operations 27.69
Cash from Investing -4.89
Cash from Financing -11.92
Net change in Cash 1.49
Free Cash Flow 33.49
Particulars MAR 2014 (Values in Cr)
Net Income 19.38
Cash from Operations 24.80
Cash from Investing 16.49
Cash from Financing -13.91
Net change in Cash 20.02
Free Cash Flow 25.94
Particulars MAR 2013 (Values in Cr)
Net Income 15.47
Cash from Operations 14.14
Cash from Investing 7.73
Cash from Financing -14.26
Net change in Cash 2.08
Free Cash Flow 15.48
Particulars MAR 2012 (Values in Cr)
Net Income 16.11
Cash from Operations 8.72
Cash from Investing 14.49
Cash from Financing -27.30
Net change in Cash -9.18
Free Cash Flow 21.48
Particulars MAR 2025 (Values in Cr)
Net Income 69.13
Cash from Operations 68.82
Cash from Investing -30.96
Cash from Financing -13.48
Net change in Cash 6.44
Free Cash Flow 104.37
Particulars MAR 2024 (Values in Cr)
Net Income 61.94
Cash from Operations 44.40
Cash from Investing 19.16
Cash from Financing -48.26
Net change in Cash -1.19
Free Cash Flow 51.12
Particulars MAR 2023 (Values in Cr)
Net Income 53.64
Cash from Operations 36.24
Cash from Investing -2.47
Cash from Financing -14.98
Net change in Cash 2.71
Free Cash Flow 45.17
Particulars MAR 2022 (Values in Cr)
Net Income 90.57
Cash from Operations 76.38
Cash from Investing -36.21
Cash from Financing -16.70
Net change in Cash -0.71
Free Cash Flow 99.85
Particulars MAR 2021 (Values in Cr)
Net Income 81.90
Cash from Operations 109.56
Cash from Investing -87.76
Cash from Financing -7.42
Net change in Cash -4.31
Free Cash Flow 109.56
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 31.51 13.02 1.52 241.47 23.12 38.85
BLISS GVS PHARMA LTD. 492.50 39.98 4.37 5223.27 118.35 495.00
CIPLA LTD. 1440.30 30.57 3.37 116353.96 1165.55 1672.20
FERMENTA BIOTECH LTD. 365.50 16.12 2.64 1075.70 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2358.85 41.53 17.62 39960.34 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 31.51 22.03 4.05 241.47 23.12 38.85
ASTRAZENECA PHARMA INDIA LTD. 8382.65 109.48 24.01 20956.63 7630.00 9850.00
BLISS GVS PHARMA LTD. 492.50 53.13 4.52 5223.27 118.35 495.00
ABBOTT INDIA LTD. 25591.00 35.04 11.39 54380.88 25164.00 35921.55

AMRUTAJAN HEALTH LTD shareholding pattern

Holding
38.64%
46.51%
2.17%
12.66%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

AMRUTAJAN HEALTH LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
537.30 0.31 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 542.30
  • 26 Days 550.50
  • 10 Days 545.60
  • 50 Days 554.70
  • 12 Days 546.50
  • 100 Days 571.90
  • 20 Days 549.30
  • 200 Days 607.60
541.03 PIVOT
First Support 526.17 First Resistance 550.47 Second Support 516.73 Second Resistance 565.33 Third Support 501.87 Third Resistance 574.77
RSI 42.57 ADX 18.30 MACD -3.94 Williams % R -86.44 Commodity Channel Index (CCI) -120.85
Date 2026-06-25 Week 25783.00 Same Day 11433.00 Month 22274.00
1 Year 0.51 3 Year 0.64
Over 1 Month
-4.53% down
Over 1 Year
-26.61% down
Over 3 Months
3.48% down
Over 3 Years
-5.34% down
Over 6 Months
-21.42% down
Over 5 Years
-4.49% down

AMRUTAJAN HEALTH LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
06 Feb 2026 1.0 Interim 2 07 Feb 2026 Equity shares
18 Nov 2025 1.0 Interim 1 18 Nov 2025 Equity shares
16 Sep 2025 2.6 Final 16 Sep 2025 Equity shares
18 Feb 2025 1.0 Interim 2 18 Feb 2025 Equity shares
22 Nov 2024 1.0 Interim 1 22 Nov 2024 Equity shares
13 Sep 2024 2.6 Final 17 Sep 2024 Equity shares
20 Feb 2024 1.0 Interim 2 20 Feb 2024 Equity shares
23 Nov 2023 1.0 Interim 1 23 Nov 2023 Equity shares
14 Sep 2023 2.6 Final 14 Sep 2023 Equity shares
24 Feb 2023 1.0 Interim 2 24 Feb 2023 Equity shares
14 Nov 2022 1.0 Interim 1 15 Nov 2022 Equity shares
14 Sep 2022 2.6 Final 16 Sep 2022 Equity shares
18 Feb 2022 1.0 Interim 2 21 Feb 2022 Equity shares
16 Nov 2021 1.0 Interim 1 17 Nov 2021 Equity shares
15 Sep 2021 2.6 Final 16 Sep 2021 Equity shares
17 Feb 2021 0.8 Interim 2 19 Feb 2021 Equity shares
19 Nov 2020 0.8 Interim 1 20 Nov 2020 Equity shares
18 Feb 2020 1.55 Interim 2 21 Feb 2020 Equity shares
15 Nov 2019 0.55 Interim 1 18 Nov 2019 Equity shares
17 Sep 2019 1.05 Final 19 Sep 2019 Equity shares
20 Feb 2019 0.55 Interim 2 21 Feb 2019 Equity shares
12 Nov 2018 0.55 Interim 1 13 Nov 2018 Equity shares
07 Sep 2018 0.85 Final 11 Sep 2018 Equity shares
22 Feb 2018 1.1 Interim 2 23 Feb 2018 Equity shares
16 Nov 2017 1.1 Interim 1 17 Nov 2017 Equity shares
13 Sep 2017 1.65 Final 14 Sep 2017 Equity shares
16 Feb 2017 1.1 Interim 2 17 Feb 2017 Equity shares
17 Nov 2016 1.1 Interim 1 18 Nov 2016 Equity shares
18 Mar 2016 2.65 Interim 2 21 Mar 2016 Equity shares
17 Feb 2016 1.2 Interim 19 Feb 2016 Equity shares
10 Sep 2015 2.4 Final 12 Sep 2015 Equity shares
13 Feb 2015 1.1 Interim 17 Feb 2015 Equity shares
17 Sep 2014 2.2 Final 19 Sep 2014 Equity shares
17 Feb 2014 1.0 Interim 19 Feb 2014 Equity shares
02 Aug 2013 2.0 Final 06 Aug 2013 Equity shares
21 Feb 2013 1.0 Interim 22 Feb 2013 Equity shares
20 Sep 2012 10.0 Final 24 Sep 2012 Equity shares
23 Feb 2012 5.0 Interim 24 Feb 2012 Equity shares
12 Sep 2011 10.0 Final 14 Sep 2011 Equity shares
21 Feb 2011 5.0 Interim 22 Feb 2011 Equity shares
13 Aug 2010 10.0 Final 17 Aug 2010 Equity shares
09 Feb 2010 5.0 Interim 10 Feb 2010 Equity shares
16 Sep 2009 12.0 Final 18 Sep 2009 Equity shares
04 Feb 2009 5.0 Interim 05 Feb 2009 Equity shares
08 Sep 2008 3.0 Final 10 Sep 2008 Equity shares
28 Jul 2008 40.0 Interim 29 Jul 2008 Equity shares
05 Feb 2008 4.0 Interim 06 Feb 2008 Equity shares
03 Aug 2007 2.0 Final 07 Aug 2007 Equity shares
24 Jan 2007 4.0 Interim 25 Jan 2007 Equity shares
29 Jul 2005 0.0 Final 02 Aug 2005 Equity shares
14 Feb 2005 0.0 Interim 15 Feb 2005 Equity shares
Ex-Date Old FV NEW FV Record Date
13 Apr 2018 2.0 1.0 16 Apr 2018
25 Oct 2012 10.0 2.0 29 Oct 2012
Dividend date Dividend amount Dividend type Record date Instrument type
06 Feb 2026 1.0 Interim 2 07 Feb 2026 Equity shares
18 Nov 2025 1.0 Interim 1 18 Nov 2025 Equity shares
16 Sep 2025 2.6 Final 16 Sep 2025 Equity shares
18 Feb 2025 1.0 Interim 2 18 Feb 2025 Equity shares
22 Nov 2024 1.0 Interim 1 22 Nov 2024 Equity shares
13 Sep 2024 2.6 Final 17 Sep 2024 Equity shares
20 Feb 2024 1.0 Interim 2 20 Feb 2024 Equity shares
23 Nov 2023 1.0 Interim 1 23 Nov 2023 Equity shares
14 Sep 2023 2.6 Final 14 Sep 2023 Equity shares
24 Feb 2023 1.0 Interim 2 24 Feb 2023 Equity shares
14 Nov 2022 1.0 Interim 1 15 Nov 2022 Equity shares
14 Sep 2022 2.6 Final 16 Sep 2022 Equity shares
18 Feb 2022 1.0 Interim 2 21 Feb 2022 Equity shares
16 Nov 2021 1.0 Interim 1 17 Nov 2021 Equity shares
15 Sep 2021 2.6 Final 16 Sep 2021 Equity shares
17 Feb 2021 0.8 Interim 2 19 Feb 2021 Equity shares
19 Nov 2020 0.8 Interim 1 20 Nov 2020 Equity shares
18 Feb 2020 1.55 Interim 2 21 Feb 2020 Equity shares
15 Nov 2019 0.55 Interim 1 18 Nov 2019 Equity shares
17 Sep 2019 1.05 Final 19 Sep 2019 Equity shares
20 Feb 2019 0.55 Interim 2 21 Feb 2019 Equity shares
12 Nov 2018 0.55 Interim 1 13 Nov 2018 Equity shares
07 Sep 2018 0.85 Final 11 Sep 2018 Equity shares
22 Feb 2018 1.1 Interim 2 23 Feb 2018 Equity shares
16 Nov 2017 1.1 Interim 1 17 Nov 2017 Equity shares
13 Sep 2017 1.65 Final 14 Sep 2017 Equity shares
16 Feb 2017 1.1 Interim 2 17 Feb 2017 Equity shares
17 Nov 2016 1.1 Interim 1 18 Nov 2016 Equity shares
18 Mar 2016 2.65 Interim 2 21 Mar 2016 Equity shares
17 Feb 2016 1.2 Interim 19 Feb 2016 Equity shares
10 Sep 2015 2.4 Final 12 Sep 2015 Equity shares
13 Feb 2015 1.1 Interim 17 Feb 2015 Equity shares
17 Sep 2014 2.2 Final 19 Sep 2014 Equity shares
17 Feb 2014 1.0 Interim 19 Feb 2014 Equity shares
02 Aug 2013 2.0 Final 06 Aug 2013 Equity shares
21 Feb 2013 1.0 Interim 22 Feb 2013 Equity shares
20 Sep 2012 10.0 Final 24 Sep 2012 Equity shares
23 Feb 2012 5.0 Interim 24 Feb 2012 Equity shares
12 Sep 2011 10.0 Final 14 Sep 2011 Equity shares
21 Feb 2011 5.0 Interim 22 Feb 2011 Equity shares
13 Aug 2010 10.0 Final 17 Aug 2010 Equity shares
09 Feb 2010 5.0 Interim 10 Feb 2010 Equity shares
16 Sep 2009 12.0 Final 18 Sep 2009 Equity shares
04 Feb 2009 5.0 Interim 05 Feb 2009 Equity shares
08 Sep 2008 3.0 Final 10 Sep 2008 Equity shares
28 Jul 2008 40.0 Interim 29 Jul 2008 Equity shares
05 Feb 2008 4.0 Interim 06 Feb 2008 Equity shares
03 Aug 2007 2.0 Final 07 Aug 2007 Equity shares
24 Jan 2007 4.0 Interim 25 Jan 2007 Equity shares
29 Jul 2005 0.0 Final 02 Aug 2005 Equity shares
14 Feb 2005 0.0 Interim 15 Feb 2005 Equity shares
Ex-Date Old FV NEW FV Record Date
13 Apr 2018 2.0 1.0 16 Apr 2018
25 Oct 2012 10.0 2.0 29 Oct 2012

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Amrutanjan Health Care Ltd?

Answer Field

Amrutanjan Health Care Ltd share price is for NSE ₹ 537.30 & for BSE ₹ 538.05 as on Jun 25 2026 03:30 PM.

What is the Market Cap of Amrutanjan Health Care Ltd Share?

Answer Field

The market cap of Amrutanjan Health Care Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 25 2026 03:30 PM.

What is the 52 Week High and Low of Amrutanjan Health Care Ltd?

Answer Field

The 52 Week High and Low of Amrutanjan Health Care Ltd for NSE is ₹ 790.95 and ₹ 486.00 and for BSE is ₹ 789.95 and ₹ 490.00.

What is 1 year return for Amrutanjan Health Care Ltd?

Answer Field

The 1 year returns on the stock has been -26.61%.

What is the P/E Ratio of Amrutanjan Health Care Ltd Share?

Answer Field

As on Jun 25 2026 03:30 PM the price-to-earnings (PE) ratio for Amrutanjan Health Care Ltd share is 26.86.

What is the PB ratio of Amrutanjan Health Care Ltd Share?

Answer Field

As on Jun 25 2026 03:30 PM, the price-to-book (PB) ratio for Amrutanjan Health Care Ltd share is 128.06.

How to Buy Amrutanjan Health Care Ltd Share?

Answer Field

You can trade in Amrutanjan Health Care Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Amrutanjan Health Care Ltd Share on Bajaj Broking App?

Answer Field

To buy Amrutanjan Health Care Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Amrutanjan Health Care Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|